Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema.

Jia-Kang WangTzu-Lun HuangPei-Yao ChangWei-Ting HoYung-Ray HsuFang-Ting ChenYun-Ju Chen

Published in: Journal of ophthalmology (2021)

We concluded that IDI and IVR can both effectively treat vitrectomized eyes with DME. Dexamethasone implants had significantly better visual/anatomical improvement, smaller treatment number, and higher rate of elevated IOP after injection than IVR in pseudophakic vitrectomized eyes with DME in a 6-month period.

Keyphrases

optical coherence tomography
diabetic retinopathy
low dose
high dose
age related macular degeneration
soft tissue
cataract surgery
ultrasound guided
clinical evaluation